Zobrazeno 1 - 10
of 146
pro vyhledávání: '"David E. Schteingart"'
Autor:
Scott A. Langenecker, David E. Schteingart, Monica N. Starkman, Jennifer L. Davison, Bruno Giordani, Julie N. Hook, Diana Gomez-Hassan
Publikováno v:
Journal of Systems and Integrative Neuroscience. 1:48-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba43b2b4c26ef4e1bc6dbf0e7b841a6
https://doi.org/10.15761/jsin.1000110
https://doi.org/10.15761/jsin.1000110
Autor:
Mark E. Molitch, David E. Schteingart, Coleman Gross, T. Brooks Vaughan, Maria Fleseriu, Beverly M. K. Biller
Publikováno v:
Endocrine Practice. 19:313-326
Objective Cushing’s syndrome (CS) is a serious endocrine disorder caused by prolonged exposure to high cortisol levels. Initial treatment of this condition is dependent upon the cause, but is generally surgical. For patients whose hypercortisolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4774c56690a32d9e777fa3e64fdc8dbd
https://doi.org/10.4158/ep12149.ra
https://doi.org/10.4158/ep12149.ra
Autor:
Maria, Fleseriu, Beverly M K, Biller, James W, Findling, Mark E, Molitch, David E, Schteingart, Coleman, Gross, Roy, Weiss
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:2039-2049
Cushing's syndrome (CS) is a disorder associated with significant morbidity and mortality due to prolonged exposure to high cortisol concentrations.Our objective was to evaluate the safety and efficacy of mifepristone, a glucocorticoid receptor antag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772c57714dc9fd8dbb4b2fe297f8f61f
https://doi.org/10.1210/jc.2011-3350
https://doi.org/10.1210/jc.2011-3350
Autor:
David E. Schteingart
Publikováno v:
Expert Opinion on Emerging Drugs. 17:279-283
Cushing's syndrome is a complex endocrine condition resulting in excessive cortisol secretion with potential serious complications if untreated or inadequately treated, such as cardiovascular morta...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d12b8611b4cfa1a07f135844380ecd
https://doi.org/10.1517/14728214.2012.679263
https://doi.org/10.1517/14728214.2012.679263
Autor:
Monica N. Starkman, Douglas C. Noll, Emily M. Briceño, Bruno Giordani, Jon Kar Zubieta, Leslie M. Guidotti Breting, Sara L. Weisenbach, David E. Schteingart, Hadia M. Leon, Scott A. Langenecker, Michael-Paul Schallmo
Publikováno v:
Neuropharmacology. 62:217-225
Cushing syndrome (CS) is the classic condition of cortisol dysregulation, and cortisol dysregulation is the prototypic finding in Major Depressive Disorder (MDD). We hypothesized that subjects with active CS would show dysfunction in frontal and limb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b03c9097a4f32e810da3c65936c814
https://doi.org/10.1016/j.neuropharm.2011.07.006
https://doi.org/10.1016/j.neuropharm.2011.07.006
Autor:
David E. Schteingart, Irina Dobrosotskaya, Gary D. Hammer, Katherine E. Maturen, Francis P. Worden
Publikováno v:
Endocrine Practice. 17:e59-e62
Objective To describe successful long-term tumor control in metastatic adrenocortical carcinoma, a relatively rare tumor with limited treatment options outside of surgery. Methods We present the clinical, radiologic, and pathologic findings in a pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5877c0ce23ecc5e16e426d472eb75e7b
https://doi.org/10.4158/ep10390.cr
https://doi.org/10.4158/ep10390.cr
Autor:
Karin Esposito, Ellie E. Schoenbaum, Paul R. Marantz, David E. Schteingart, Doris M. Rubio, Linda S. Lee, Lauren Dewey Platt, Adriana Baez, Karl E. Anderson
Publikováno v:
Academic Medicine. 85:470-475
Because translational research is not clearly defined, developers of translational research programs are struggling to articulate specific program objectives, delineate the knowledge and skills (competencies) that trainees are expected to develop, cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1363b59d2d426a51c2e3a98870a51fa9
https://doi.org/10.1097/acm.0b013e3181ccd618
https://doi.org/10.1097/acm.0b013e3181ccd618
Autor:
Donghua Yin, Paul Haluska, M. Luisa Paccagnella, Johann S. de Bono, David E. Schteingart, Antonio Gualberto, Frank Worden, Gary D. Hammer, David Olmos, Gretchen N. Batzel
Publikováno v:
Cancer Chemotherapy and Pharmacology. 65:765-773
Insulin-like growth factor 1 receptor signaling through upregulation of the stimulatory ligand IGF-II has been implicated in the pathogenesis of adrenocortical carcinoma. As there is a paucity of effective therapies, this dose expansion cohort of a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc99089fcbd517ee7c0c934cc05e06e
https://doi.org/10.1007/s00280-009-1083-9
https://doi.org/10.1007/s00280-009-1083-9
Publikováno v:
Journal of Affective Disorders. 101:139-147
Background The basal ganglia, particularly caudate, are hypothesized to play a role in affective and obsessive-compulsive disorders. The depressive syndrome is a feature of untreated Cushing's disease. The objective of this study was to test the hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a0433280c5b606488399c349569d46
https://doi.org/10.1016/j.jad.2006.11.007
https://doi.org/10.1016/j.jad.2006.11.007
Autor:
David E. Schteingart
Publikováno v:
New England Journal of Medicine. 356:2415-2418
Adrenocortical carcinoma is a rare, highly malignant neoplasm with an incidence of 2 cases per 1 million population per year worldwide, representing 0.2% of all cases of cancer. Several treatment strategies in patients with advanced disease have resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7ee606dc8c5b9ad3ad4fd79f7f2cac9
https://doi.org/10.1056/nejme078087
https://doi.org/10.1056/nejme078087